Document is current
Any future updates will be listed below
-
Authors
Oh, Eungseok
Cheon, Sang-Myeong
Cho, Jin Whan
Sung, Young Hee
Kim, Joong-Seok
Shin, Hae-Won
Kim, Jong-Min
Park, Mee Young
Kwon, Do-Young
Ma, Hyeo II
Park, Jeong-Ho
Koh, Seong-Beom
Choi, Seong-Min
Park, Jinse
Lee, Phil Hyu
Ahn, Tae-Beom
Kim, Sang Jin
Lyoo, Chul Hyoung
Lee, Ho-Won
Kim, Jieun
Lee, Yoona
Baik, Jong Sam https://orcid.org/0000-0002-5300-203X
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05312632 at ClinicalTrials.govDocuments that mention this clinical trial
Efficacy and safety of safinamide in Parkinson’s disease patients with motor fluctuations without levodopa dosage escalation over 18 weeks: KEEP study
https://doi.org/10.1007/s00702-024-02851-6
-
Funding
Funding for this research was provided by:
Eisai Korea (Eisai Korea)
- License Information
-
More Information
Article History
Received: 30 May 2024
Accepted: 14 October 2024
First Online: 14 November 2024
Declarations
:
: Jieun Kim and Yoona Lee are employees of Eisai Korea Inc. All other authors have no relevant financial or non-financial interests to disclose.
: This study was performed in line with the principles of the Declaration of Helsinki 2013, and ICH Good Clinical Practice guidelines and Korean Good Clinical Practice guidelines. Approval was granted by the relevant Ethics Committees. Written informed consent was obtained from all study participants.
